Mirae Asset Global Investments Co., Ltd. Artivion, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Artivion, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 16,495 shares of AORT stock, worth $423,096. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,495
Previous 17,628
6.43%
Holding current value
$423,096
Previous $315,000
10.79%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AORT
# of Institutions
151Shares Held
34.9MCall Options Held
18KPut Options Held
1.5K-
Black Rock Inc. New York, NY6.74MShares$173 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.8MShares$71.8 Million0.07% of portfolio
-
Perceptive Advisors LLC New York, NY2.67MShares$68.5 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.66MShares$68.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.34MShares$59.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.03B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...